Development of mRNA vaccines and their prophylactic and therapeutic applications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of mRNA vaccines and their prophylactic and therapeutic applications
Authors
Keywords
messenger RNA (mRNA) vaccines, prophylactic vaccines, self-amplifying mRNA vaccines, therapeutic vaccine, cancer immunotherapy
Journal
Nano Research
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-31
DOI
10.1007/s12274-018-2095-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
- (2018) Hyokyoung Kwon et al. BIOMATERIALS
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+T cell trafficking
- (2018) David Taggart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of the checkpoint protein PD-1 by the therapeutic antibody pembrolizumab outlined by quantum chemistry
- (2018) Ana Beatriz M. L. A. Tavares et al. Scientific Reports
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems
- (2017) S Guan et al. GENE THERAPY
- Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1
- (2017) Hui Li et al. HEPATOLOGY
- Clinical response to PD-1 blockade correlates with a sub-fraction of peripheral central memory CD4+ T cells in patients with malignant melanoma
- (2017) Yoshiko Takeuchi et al. INTERNATIONAL IMMUNOLOGY
- State of play and clinical prospects of antibody gene transfer
- (2017) Kevin Hollevoet et al. Journal of Translational Medicine
- Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma
- (2017) Bert H. O’Neil et al. PLoS One
- Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
- (2017) Katherine E. Lewis et al. OncoImmunology
- Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial.
- (2017) M. Sebastian et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
- (2016) Jon Amund Kyte et al. OncoImmunology
- Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications
- (2015) Haipeng Liu et al. BIOCONJUGATE CHEMISTRY
- Current and next generation influenza vaccines: Formulation and production strategies
- (2015) Peter C. Soema et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
- (2014) Martin Sebastian et al. BMC CANCER
- Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
- (2014) Raquel P Deering et al. Expert Opinion on Drug Delivery
- The ReNAissanCe of mRNA-based cancer therapy
- (2014) Sandra Van Lint et al. Expert Review of Vaccines
- Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles
- (2014) C. Chauvin et al. JOURNAL OF IMMUNOLOGY
- A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
- (2014) Luis A Brito et al. MOLECULAR THERAPY
- Messenger RNA (mRNA) nanoparticle tumour vaccination
- (2014) Kyle K. L. Phua et al. Nanoscale
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model
- (2014) Zineb Belcaid et al. PLoS One
- Therapeutic vaccines for tuberculosis—A systematic review
- (2014) Matthias I. Gröschel et al. VACCINE
- Novel Monodisperse PEGtide Dendrons: Design, Fabrication, and Evaluation of Mannose Receptor-Mediated Macrophage Targeting
- (2013) Jieming Gao et al. BIOCONJUGATE CHEMISTRY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
- (2013) Satoshi Wada et al. Journal of Translational Medicine
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- Molecularly targeted cancer therapy: some lessons from the past decade
- (2013) Min Huang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice
- (2013) Armin Hekele et al. Emerging Microbes & Infections
- Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
- (2013) Aleksandra M. Dudek et al. Frontiers in Immunology
- Recombinant vaccines and the development of new vaccine strategies
- (2012) I.P. Nascimento et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
- (2012) Mariola Fotin-Mleczek et al. JOURNAL OF GENE MEDICINE
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
- (2012) Benjamin Petsch et al. NATURE BIOTECHNOLOGY
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- RNA-based vaccines
- (2012) Jeffrey B. Ulmer et al. VACCINE
- Electroporation delivery of DNA vaccines: prospects for success
- (2011) Niranjan Y Sardesai et al. CURRENT OPINION IN IMMUNOLOGY
- Viral vectors as vaccine platforms: deployment in sight
- (2011) Christine S Rollier et al. CURRENT OPINION IN IMMUNOLOGY
- Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges
- (2011) Marie-Louise Michel et al. JOURNAL OF HEPATOLOGY
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- In Vitroandin VivomRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
- (2011) Xingfang Su et al. MOLECULAR PHARMACEUTICS
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
- (2011) Nam-Hyuk Cho et al. Nature Nanotechnology
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- mRNA as gene therapeutic: How to control protein expression
- (2010) Geertrui Tavernier et al. JOURNAL OF CONTROLLED RELEASE
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Rational design of cationic lipids for siRNA delivery
- (2010) Sean C Semple et al. NATURE BIOTECHNOLOGY
- Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications
- (2010) Malwina Strenkowska et al. NEW JOURNAL OF CHEMISTRY
- Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
- (2010) Yanelys Morera et al. VACCINE
- In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA–DNA carrying microparticles to dendritic cells
- (2009) Ankur Singh et al. BIOMATERIALS
- A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation
- (2009) X. Zheng et al. BLOOD
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- Recent Advances in Cancer Therapy: An Overview
- (2009) A. Urruticoechea et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic vaccines in solid tumours: Can they be harmful?
- (2009) Alexander M.M. Eggermont EUROPEAN JOURNAL OF CANCER
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
- (2009) Salvatore Siena et al. JNCI-Journal of the National Cancer Institute
- Knocking down barriers: advances in siRNA delivery
- (2009) Kathryn A. Whitehead et al. NATURE REVIEWS DRUG DISCOVERY
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding
- (2008) Sjoerd H van der Burg Expert Review of Vaccines
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
- DNA vaccines: ready for prime time?
- (2008) Michele A. Kutzler et al. NATURE REVIEWS GENETICS
- Potential chemotherapy side effects: What do oncologists tell parents?
- (2008) Lisa Ysela Ramirez et al. PEDIATRIC BLOOD & CANCER
- Vaccination and antigenic drift in influenza
- (2008) Maciej F. Boni VACCINE
- Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein
- (2008) Sonal Saxena et al. VETERINARY MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started